218
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Identification of a new tadalafil analogue in commercial dietary supplements: isopropylnortadalafil

, , , &
Pages 162-169 | Received 13 Sep 2016, Accepted 19 Nov 2016, Published online: 22 Dec 2016
 

ABSTRACT

A new tadalafil analogue was found in a commercial dietary supplement for enhancing sexual performance. The compound was detected by a high-performance liquid chromatography-diode array detector (HPLC-DAD). The analogue was isolated using semi-preparative HPLC, and its accurate mass was established by two LC-high-resolution-mass spectrometers (LC-HRMS). The structure was determined by nuclear magnetic resonance (NMR) spectroscopy. The accurate mass of the compound corresponded to a molecular formula of C24H23N3O4. The compound was identified as a structural analogue of tadalafil in which the N-methyl group of tadalafil was replaced with an N-isopropyl group. We have named the new analogue isopropylnortadalafil and it is first reported herein.

GRAPHICAL ABSTRACT

Acknowledgment

The authors thank the Central Laboratory of Kangwon National University for providing them with technical assistance for the spectroscopic experiments. Han Na Park and Ji Hyun Lee contributed equally to this work.

Disclosure statement

No potential conflict of interest was reported by the authors.

Supplemental material

Supplemental data for this article can be accessed here.

Additional information

Funding

This work was supported by the Ministry of Food and Drug Safety [grant numbers MFDSAAT2016 and 15182MFDS523]; and Kangwon National University.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.